A carregar...
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
Elevated post-prandial lipoprotein levels are common in patients with type 2 diabetes. Post-prandial lipoprotein alterations in type 2 diabetics are widely believed to drive inflammation and are considered a major risk factor for cardiovascular disease in diabetic patients. The incretins glucagon li...
Na minha lista:
| Publicado no: | Clin Lipidol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437760/ https://ncbi.nlm.nih.gov/pubmed/26005496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.14.59 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|